Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NITRAZEPAM vs NIVOLUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NITRAZEPAM vs NIVOLUMAB: Safety Overview

Metric NITRAZEPAM NIVOLUMAB
Total FAERS Reports 1,165 87,742
Deaths Reported 365 23,086
Death Rate 31.3% 26.3%
Hospitalizations 466 36,530
Average Patient Age 51.2 yrs 64.2 yrs
% Female Patients 54.1% 34.0%
Manufacturer N/A E.R. Squibb & Sons, L.L.C.
Route N/A INTRAVENOUS
Marketing Status N/A Prescription